ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023
Overall Survival Analysis of the Use of Elotuzumab in ELOQUENT-3 Trial.
Samer Al Hadidi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.